Co-Diagnostics, Inc.
CODX
$0.56
$0.04639.01%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.70M | -7.60M | -9.31M | -14.68M | -5.98M |
| Total Depreciation and Amortization | 351.20K | 338.30K | 330.60K | 312.90K | 296.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 879.50K | 1.75M | 1.01M | 9.09M | -529.10K |
| Change in Net Operating Assets | 1.24M | 304.60K | -515.30K | 494.10K | 449.70K |
| Cash from Operations | -7.23M | -5.20M | -8.49M | -4.78M | -5.77M |
| Capital Expenditure | -174.40K | -98.60K | -402.30K | -464.60K | -236.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.34M | -3.94M | 17.08M | 10.08M | 2.58M |
| Cash from Investing | 4.17M | -4.04M | 16.67M | 9.62M | 2.34M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -159.70K | -166.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -159.70K | -166.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.06M | -9.24M | 8.18M | 4.68M | -3.59M |
